首页> 外国专利> INHIBITOR OF CIRRHOSIS AND PRECANCEROUS LESION USING NATRIURETIC PEPTIDE AS ACTIVE INGREDIENT

INHIBITOR OF CIRRHOSIS AND PRECANCEROUS LESION USING NATRIURETIC PEPTIDE AS ACTIVE INGREDIENT

机译:以利尿钠肽为有效成分抑制肝硬化和癌前病变

摘要

PPROBLEM TO BE SOLVED: To provide a medicinal composition for inhibiting hepatic fibrosis, serving to prevent or treat cirrhosis or precancerous lesion by using a natriuretic peptide as an active ingredient. PSOLUTION: It is discovered that the natriuretic peptide has the inhibiting effects against the hepatic fibrosis by examining the in-vivo effects of the natriuretic peptide to an active stellate cell of the liver by paying attention to the stellate cell of the liver which can be said as a "target cell" in the prevention or treatment of the hepatic fibrosis, and considering that the inhibition of the activation of the stellate cell of the liver is important, and the invention is completed. PCOPYRIGHT: (C)2010,JPO&INPIT
机译:<要解决的问题:提供一种抑制肝纤维化的药物组合物,其通过使用利钠肽作为活性成分来预防或治疗肝硬化或癌前病变。

解决方案:通过关注肝脏的星状细胞来检查利钠肽对肝脏活性星状细胞的体内作用,从而发现利钠肽对肝纤维化具有抑制作用。可以说是在预防或治疗肝纤维化中的“靶细胞”,并且考虑到抑制肝星状细胞的活化很重要,从而完成了本发明。

版权:(C)2010,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号